GSK

BENLYSTA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

GSK

Benlysta HCPCS:

J0490

HCPCS Code Descriptor:

Injection, belimumab, 10 mg

Category:

J Code

Benlysta NDCs:

49401-0102-01, 49401-0101-01

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Intravenous

Benlysta CPT Codes:

Potential CPT administration codes for Benlysta can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Benlysta:

BENLYSTA is an Immunology drug manufactured by GSK and administered via the Intravenous route of administration. The J Code: J0490 is aligned to the drug BENLYSTA.

Benlysta is a type of immunosuppressant drug that is approved by the FDA for the treatment of lupus and lupus nephritis. Benlysta is thought to work against a protein in the body that triggers your immune system to attack different parts of the body. Benlysta is thought to protect healthy cells from damage, which may slow the progression of the disease. Benlysta may be given to patients with mild or moderate lupus that affects the blood, skin, joints, and kidneys. It may be given by infusion or injection.

ACCESS PRICING AND MORE BY REGISTERING

J0490 Added Date:

January 1, 2012

J0490 Effective Date:

January 1, 2012

J0490 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Benlysta billing and coding information.
Benlysta patient assistance information can be found through GSK for You at the URL: http://www.gskforyou.com/
BENLYSTA prescribing information can be found at the link below:
Information regarding BENLYSTA’s side effects can be found at MedlinePlus